Edwards Lifesciences Corp.
Congress has disclosed 18 buys and 15 sells of EW (Edwards Lifesciences Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying EW and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rob Bresnahan | 2025-04-08 | $67.07 | $92.01 | +37.2% | in profit |
| Alan Armstrong | 2026-03-27 | $79.34 | $92.01 | +16.0% | in profit |
| Rohit Khanna | 2026-05-01 | $83.98 | $92.01 | +9.6% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
33 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2026-05-01 | 38 days | +2.2% | $1K–$15K | 13.9 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | +6.6% | $1K–$15K | 99.1 | ↗ eFD |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-11-19 | 15 days | -0.3% | $1K–$15K <0.1% of NW |
27.3 | ↗ filing |
| Bruce Westerman | House | SELL ◆ insider convergence | Self · Fisher IRA | 2025-04-21 | 7 days | +9.2% | $1K–$15K 0.7% of NW |
30.1 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Bruce Westerman | House | BUY ◆ insider divergence | Self · Fisher IRA | 2025-03-03 | 14 days | -1.1% | $1K–$15K 0.7% of NW |
65.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-10-14 | 24 days | -5.4% | $1K–$15K | 10.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-09-09 | 23 days | -0.9% | $1K–$15K | 15.7 | ↗ filing |
| Mike Kelly | House | SELL ◆ insider divergence · strong | Spouse | 2024-04-11 | 34 days | — | $1K–$15K 0.1% of NW |
97.3 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-12-11 | 24 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-12-05 | 30 days | — | $1K–$15K | 31.8 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence | Joint · Northwestern Mutual - Joint | 2023-12-04 | 0 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-08-29 | 7 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-08-11 | 25 days | — | $1K–$15K | 75.9 | ↗ filing |
| John Curtis | House | BUY ◆ insider divergence · moderate | Joint · Northwestern Mutual - Joint | 2023-06-21 | 26 days | — | $1K–$15K | 40.4 | ↗ filing |
| Zoe Lofgren | House | SELL ◆ insider convergence | Spouse · John Marshall Collins Rollover IRA | 2023-05-25 | 12 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| John Curtis | House | BUY ◆ insider divergence | Joint · Northwestern Mutual - Joint | 2023-04-26 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence · moderate | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $15K–$50K <0.1% of NW |
90.9 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2021-09-16 | 27 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Zoe Lofgren | House | BUY | Spouse | 2021-09-02 | 35 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Zoe Lofgren | House | BUY | Spouse | 2021-08-09 | 31 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2021-07-27 | 17 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-01-28 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2020-11-05 | 53 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Zoe Lofgren | House | SELL | Spouse | 2020-03-23 | 0 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2019-07-30 | 9 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2019-03-20 | 12 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2017-11-01 | 33 days | — | $1K–$15K | 22.3 | ↗ filing |
| Zoe Lofgren | House | BUY | Spouse | 2017-06-15 | 27 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2017-06-12 | 21 days | — | $1K–$15K | 40.4 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2016-12-12 | 22 days | — | $1K–$15K | 75.9 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2014-02-14 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in EW — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in EW, 4 coincided with corporate insiders moving the same way within 60 days, and 14 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | Other | SELL 10b5-1 | $53K | ↗ EDGAR |
| 2026-09-11 | Lippis Daniel J. | Other | SELL 10b5-1 | $54K | ↗ EDGAR |
| 2026-08-31 | Dahl Andrew M. | Other | SELL | $50K | ↗ EDGAR |
| 2026-08-28 | Bruls Annette | Other | SELL | $238K | ↗ EDGAR |
| 2026-08-26 | Markowitz Wayne | Other | SELL | $113K | ↗ EDGAR |
| 2026-08-26 | Chopra Daveen | Other | SELL | $106K | ↗ EDGAR |
| 2026-08-26 | Chopra Daveen | Other | SELL | $2.8M | ↗ EDGAR |
| 2026-08-11 | Lippis Daniel J. | Other | SELL 10b5-1 | $57K | ↗ EDGAR |
| 2026-07-30 | Markowitz Wayne | Other | SELL | $13K | ↗ EDGAR |
| 2026-07-28 | Markowitz Wayne | Other | SELL | $819K | ↗ EDGAR |
| 2026-07-27 | Zovighian Bernard J | C-suite | SELL | $245K | ↗ EDGAR |
| 2026-07-10 | Lippis Daniel J. | Other | SELL 10b5-1 | $57K | ↗ EDGAR |
| 2026-06-30 | Lippis Daniel J. | Other | SELL 10b5-1 | $57K | ↗ EDGAR |
| 2026-06-17 | Zovighian Bernard J | C-suite | SELL 10b5-1 | $46K | ↗ EDGAR |
| 2026-05-29 | Dahl Andrew M. | Other | SELL | $49K | ↗ EDGAR |
| 2026-05-27 | BOBO DONALD E JR | Other | SELL | $2.0M | ↗ EDGAR |
| 2026-05-22 | Chopra Daveen | Other | SELL | $127K | ↗ EDGAR |
| 2026-05-18 | Lippis Daniel J. | Other | SELL 10b5-1 | $50K | ↗ EDGAR |
| 2026-05-15 | BOBO DONALD E JR | Other | SELL | $818K | ↗ EDGAR |
| 2026-05-15 | BOBO DONALD E JR | Other | SELL | $655K | ↗ EDGAR |
| 2026-05-12 | Zovighian Bernard J | C-suite | SELL 10b5-1 | $66K | ↗ EDGAR |
| 2026-05-12 | Zovighian Bernard J | C-suite | SELL 10b5-1 | $2.8M | ↗ EDGAR |
| 2026-05-11 | Markowitz Wayne | Other | SELL | $47K | ↗ EDGAR |
| 2026-05-04 | Lippis Daniel J. | Other | SELL 10b5-1 | $86K | ↗ EDGAR |
| 2026-05-01 | Lippis Daniel J. | Other | SELL 10b5-1 | $2K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-08 | Lippis Daniel J. Other 10b5-1 | SELL | $53K |
| ◆ insider | 2026-09-11 | Lippis Daniel J. Other 10b5-1 | SELL | $54K |
| ◆ insider | 2026-08-31 | Dahl Andrew M. Other | SELL | $50K |
| ◆ insider | 2026-08-28 | Bruls Annette Other | SELL | $238K |
| ◆ insider | 2026-08-26 | Markowitz Wayne Other | SELL | $113K |
| ◆ insider | 2026-08-26 | Chopra Daveen Other | SELL | $106K |
| ◆ insider | 2026-08-26 | Chopra Daveen Other | SELL | $2.8M |
| ◆ insider | 2026-08-11 | Lippis Daniel J. Other 10b5-1 | SELL | $57K |
| ◆ insider | 2026-07-30 | Markowitz Wayne Other | SELL | $13K |
| ◆ insider | 2026-07-28 | Markowitz Wayne Other | SELL | $819K |
| ◆ insider | 2026-07-27 | Zovighian Bernard J C-suite | SELL | $245K |
| ◆ insider | 2026-07-10 | Lippis Daniel J. Other 10b5-1 | SELL | $57K |
| ◆ insider | 2026-06-30 | Lippis Daniel J. Other 10b5-1 | SELL | $57K |
| ◆ insider | 2026-06-17 | Zovighian Bernard J C-suite 10b5-1 | SELL | $46K |
| ◆ insider | 2026-05-29 | Dahl Andrew M. Other | SELL | $49K |
| ◆ insider | 2026-05-27 | BOBO DONALD E JR Other | SELL | $2.0M |
| ◆ insider | 2026-05-22 | Chopra Daveen Other | SELL | $127K |
| ◆ insider | 2026-05-18 | Lippis Daniel J. Other 10b5-1 | SELL | $50K |
| ◆ insider | 2026-05-15 | BOBO DONALD E JR Other | SELL | $818K |
| ◆ insider | 2026-05-15 | BOBO DONALD E JR Other | SELL | $655K |
| ◆ insider | 2026-05-12 | Zovighian Bernard J C-suite 10b5-1 | SELL | $66K |
| ◆ insider | 2026-05-12 | Zovighian Bernard J C-suite 10b5-1 | SELL | $2.8M |
| ◆ insider | 2026-05-11 | Markowitz Wayne Other | SELL | $47K |
| ◆ insider | 2026-05-04 | Lippis Daniel J. Other 10b5-1 | SELL | $86K |
FAQ Common questions
How much has Congress traded EW?
18 disclosed buys and 15 sells of EW (Edwards Lifesciences Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade EW?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.